<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20">
 <label>20</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Grätz</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Langan</surname>
    <given-names>EA</given-names>
   </name>
   <name>
    <surname>Neumann</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Zillikens</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Terheyden</surname>
    <given-names>P</given-names>
   </name>
  </person-group>. 
  <article-title>Acute neurological adverse events during immune checkpoint inhibition therapy in patients with melanoma brain metastases</article-title>. 
  <source>Melanoma Res</source> (
  <year>2019</year>) 
  <volume>29</volume>:
  <page-range>516–21</page-range>.  
  <pub-id pub-id-type="doi">10.1097/cmr.0000000000000597</pub-id>
 </mixed-citation>
</ref>
